Effect of vitamin D on quality of life in fibromyalgia pateints
Phase 3
- Conditions
- fibromyalgia syndrome.Other soft tissue disorders, not elsewhere classified
- Registration Number
- IRCT2012100610960N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
20-70 years old females who fill ACR criteria 2010 of fibromyalgia and 25OHD level less than 30 ng/ml. Exclusions: rheumatologic disease; metabolic bone disease; diabetes; major depression; liver diseases; chronic kidney disease; cancer; malabsorption; pregnancy; steroid user; any extra-protocol vitamin D consumption; patients who had been treated with trazodon previously with no response.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: On the day of recruitment ,4 and 8 weeks later. Method of measurement: SF36 and EQ-5D questionere.
- Secondary Outcome Measures
Name Time Method Rising of 25OH D level, comparison of sleep questioneer score before and after intervention in each group. Timepoint: on 1st day of recuitment, 4 and 8 weeks after intervention. Method of measurement: ELISA.